Shouryadeep Srivastava
Corporate Officer/Principal chez THESEUS PHARMACEUTICALS, INC.
Profil
Shouryadeep Srivastava is currently working as Vice President-Clinical Development at Theseus Pharmaceuticals, Inc. He holds a doctorate degree from Texas Tech University and Baba Raghav Das Medical College.
Postes actifs de Shouryadeep Srivastava
| Sociétés | Poste | Début |
|---|---|---|
| THESEUS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Shouryadeep Srivastava
| Texas Tech University | Doctorate Degree |
| Baba Raghav Das Medical College | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Theseus Pharmaceuticals, Inc.
 Theseus Pharmaceuticals, Inc. BiotechnologyHealth Technology Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA. | Health Technology |
